Kyntra Bio, Inc. (KYNB) — Working Capital to Net Assets Ratio
Kyntra Bio, Inc. (KYNB) has a Working Capital to Net Assets ratio of 1560.5% as of December 2025. Working capital of $69.83 Million (current assets of $99.07 Million minus current liabilities of $29.24 Million) is measured against net assets of $4.47 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Kyntra Bio, Inc. financial flexibility index to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Kyntra Bio, Inc. Working Capital to Net Assets (2012–2025)
This chart shows how Kyntra Bio, Inc.'s Working Capital to Net Assets ratio has evolved across 14 annual periods from 2012 to 2025. As of December 2025, the ratio stands at 1560.5%, reflecting working capital of $69.83 Million against net assets of $4.47 Million USD. See defensive interval ratio of Kyntra Bio, Inc. to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Kyntra Bio, Inc. (2012–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Kyntra Bio, Inc. from 2012 to 2025, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see KYNB market cap.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 1560.5% | $69.83 Million | $4.47 Million | $99.07 Million | $29.24 Million | ▲ +1594.9 pp |
| 2024 | -34.4% | $63.20 Million | $-183.63 Million | $196.51 Million | $133.31 Million | ▲ +35.8 pp |
| 2023 | -70.2% | $113.89 Million | $-162.20 Million | $331.56 Million | $217.67 Million | ▲ +14744.9 pp |
| 2022 | -14815.1% | $219.26 Million | $-1.48 Million | $492.83 Million | $273.56 Million | ▼ -14923.6 pp |
| 2021 | 108.5% | $248.56 Million | $229.11 Million | $474.06 Million | $225.50 Million | ▼ -25.6 pp |
| 2020 | 134.1% | $591.92 Million | $441.45 Million | $755.11 Million | $163.19 Million | ▲ +22.1 pp |
| 2019 | 112.0% | $599.75 Million | $535.41 Million | $702.49 Million | $102.75 Million | ▼ -1.7 pp |
| 2018 | 113.7% | $600.98 Million | $528.47 Million | $690.01 Million | $89.03 Million | ▼ -1.6 pp |
| 2017 | 115.3% | $671.71 Million | $582.45 Million | $748.97 Million | $77.26 Million | ▲ +0.3 pp |
| 2016 | 115.0% | $201.39 Million | $175.11 Million | $266.52 Million | $65.12 Million | ▲ +47.2 pp |
| 2015 | 67.8% | $133.38 Million | $196.82 Million | $200.56 Million | $67.18 Million | ▲ +11.5 pp |
| 2014 | 56.3% | $135.48 Million | $240.68 Million | $198.24 Million | $62.75 Million | ▼ -42.4 pp |
| 2013 | 98.7% | $106.16 Million | $107.60 Million | $143.64 Million | $37.48 Million | ▲ +74.8 pp |
| 2012 | 23.8% | $29.12 Million | $122.18 Million | $52.80 Million | $23.68 Million | — |